Reboot Rx Inc

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 844384737 ✦ Winchester, MA ✦ Designated as a 501(c)(3)

Overview

What is Reboot Rx Inc?

Reboot Rx Inc, based in Winchester, Massachusetts, is a nonprofit organization dedicated to revolutionizing cancer treatment accessibility. Through the repurposing of generic drugs, they aim to make low-cost cancer treatments widely available. Utilizing advanced AI technology, strategic partnerships, and innovative funding models, Reboot Rx seeks to expedite the delivery of promising generic drugs to cancer patients, offering them an alternative to traditional treatment methods. With a team of 13 dedicated individuals, the organization continues its mission to empower cancer patients by providing them with new and affordable treatment options more swiftly than conventional approaches.


Official website here: www.rebootrx.org

Is Reboot Rx Inc legitimate?

Reboot Rx Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Reboot Rx Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $186,707
Professional Fundraising Fees: $0
Other Salaries and Wages: $260,060

For more financial information, click here


Official website here: www.rebootrx.org

What is the mission statement of Reboot Rx Inc?

Reboot Rx Inc, as a nonprofit organization, is dedicated to facilitating cancer patients' access to new and affordable treatments at a faster pace than conventional methods. They achieve this mission through the repurposing of generic drugs, employing advanced AI technology, strategic partnerships, and innovative funding models. By utilizing these methods, Reboot Rx strives to bring the most promising generic treatments to cancer patients more swiftly, ultimately improving their chances of recovery.


Official website here: www.rebootrx.org

Who is the CEO of Reboot Rx Inc?

David Noymer is the President Ceo And Director of Reboot Rx Inc. The CEO's salary of Reboot Rx Inc is $121,462 and their total compensation is $126,320.


Official website here: www.rebootrx.org

What is the revenue of Reboot Rx Inc?

Reboot Rx Inc's revenue in 2023 was $520,612.


Official website here: www.rebootrx.org

Who are the executives of Reboot Rx Inc and what are their salaries?

The average compensation at Reboot Rx Inc during 2023 was $34,367. There are 13 employees at Reboot Rx Inc.

Here are 7 key members and their salaries (Reboot Rx Inc's CEO's salary is $121,462 and their total compensation is $126,320):

    Laura Kleiman (President Ceo And Director)
  • Compensation: $121,462
  • Related: $0
  • Other: $4,858

    • Pradeep Mangalath (Chief Operating & Tech Office) [Trustee/Director]
  • Compensation: $109,615
  • Related: $0
  • Other: $4,385

    • Robert Pozen (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Lara Metcalf (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Mason Irving Iii (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Andrea Pollinger (Board Chair And Clerk) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • David Noymer (Treasurer) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.rebootrx.org

    Where can I find the form 990 for Reboot Rx Inc?

    The Reboot Rx Inc’s most recent form 990 was submitted in 2023 and can be accessed here


    Official website here: www.rebootrx.org

    Learn more at the official website: www.rebootrx.org

    Mission Statement of Reboot Rx Inc

    Reboot Rx, a nonprofit organization, is dedicated to revolutionizing the way cancer patients access affordable treatments. Their mission is to expedite the availability of cost-effective cancer therapies for all patients, surpassing the pace set by conventional approaches. They achieve this by leveraging artificial intelligence technology, strategic collaborations, and innovative funding models. By repurposing generic drugs, Reboot Rx aims to bring the most promising treatments to cancer patients more quickly.

    Impact

    This information is meant to be a general summary of Reboot Rx Inc. Please take the time to review official sources before making any decisions based upon the content provided here.




    Wednesday, July 24, 2024

    Reboot Rx Inc's impact lies in its ability to enable cancer patients to access new and affordable treatments more quickly than traditional approaches. By repurposing generic drugs and utilizing AI technology, strategic partnerships, and innovative funding models, Reboot Rx is dedicated to making low-cost cancer treatments accessible for all. Through their work, they are striving to get the most promising generics to cancer patients, ultimately improving outcomes and providing hope to those in need.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2023.

  • Investment Income: $25,440
  • Program Service Revenue: $0
  • Gross Receipts: $520,612

    • Assets and Liabilities:
  • Total Assets: $982,557
  • Total Liabilities: $185,671
  • Net Assets: $796,886
  • Organization Details

    Founding Year

    2020

    Principal Officer

    David Noymer

    Main Address

    45 Thornberry Road, Winchester, MA, 01890

    NTEE Category

    Code: H30 - Medical research

    If you are a representative of Reboot Rx Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.